Allergan closes the book on Fetzima generics suit

16-09-2021

Alex Baldwin

Allergan closes the book on Fetzima generics suit

rafapress / Shutterstock.com

Allergan has struck a deal with two generic manufacturers to resolve a long-running patent infringement suit over its antidepressant drug Fetzima (Levomilnacipran).


Allergan, Fetzima, US District Court for the District of New Jersey, MSN Laboratories, Aurobindo Pharma, generics

LSIPR